The National Academies: Advisers to the Nation on Science, Engineering, and Medicine
NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL
Current Operating Status

The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

Request a Report (Congressional and Government Staff Only)


Mailing Address:
The Office of Congressional and Government Affairs
The Keck Center of the National Academies
Keck WS1008
500 Fifth Street, NW
Washington, DC 20001
Tel: (202) 334-1601
Fax: (202) 334-2419

Back to Main Page

Briefing Date:12/13/2011
Topic:Scientific Standards for Studies on Modified Risk Tobacco Products

THE NATIONAL ACADEMIES
Institute of Medicine
Board on Population Health and Public Health Practice
Committee on Scientific Standards for Studies on Modified Risk Tobacco Products

*****

Congressional Briefings
Tuesday, December 13, 2011
2218 Rayburn House Office Bldg. – 10:00 a.m.
and
430 Dirksen Senate Office Bldg. – 4:00 p.m.

on

Scientific Standards for Studies on Modified Risk Tobacco Products

by

Jane E. Henney, M.D., Professor of Medicine and Public Health Sciences, College of Medicine, University of Cincinnati at Cincinnati; and Chair, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies

Bonnie L. Halpern-Felsher, Ph.D., Professor, Department of Pediatrics, Division of Adolescent Medicine, University of California at San Francisco; and Member, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies

and

Richard O'Connor, Ph.D., Associate Member, Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, N.Y.; and Member, Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, Institute of Medicine, The National Academies

Modified risk tobacco products aim to reduce tobacco-related illnesses, and the Food and Drug Administration (FDA) is responsible for their scientific assessment and ongoing review. This new report, from the Institute of Medicine, advises FDA on the minimum standards for scientific studies to allow the marketing of modified risk tobacco products and for postmarket studies of approved products.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on December 14, 2011 and can be found, in its entirety, on the Web site of the National Academies Press.

RSS News Feed | Subscribe to e-newsletters | Feedback | Back to Top